Anti-Human CD70 Recombinant Antibody (Vorsetuzumab) (CAT#: TAB-H76)
Recombinant Humanized (from mouse) antibody to Human CD70. Vorsetuzumab is a monoclonal antibody designed for the treatment of cancer.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Figure 1 Treatment with vorsetuzumab and KWAR23 led to strong inhibition of tumor growth in SRG mice.
Tumor growth in SRG mice treated with PBS (n = 7), vorsetuzumab (n = 3), vorsetuzumab + KWAR23 (n = 5), or bispecific anti-CD70/KWAR23 (n = 6). The color of the stars indicates comparison of the PBS group with the corresponding treatment group. ns, not significant.
Ring, N. G., Herndler-Brandstetter, D., Weiskopf, K., Shan, L., Volkmer, J. P., George, B. M., ... & Zheng, Y. (2017). Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. Proceedings of the National Academy of Sciences, 114(49), E10578-E10585.
Figure 2 In vitro experiments show that KWAR23 only moderately induced macrophage phagocytosis of four different renal carcinoma cell lines (RCC4, RCC10, TK10, and Caki-1) following incubation with the anti-human CD70 antibody vorsetuzumab.
Phagocytosis of four different renal carcinoma cells by human macrophages following treatment with vorsetuzumab, vorsetuzumab + KWAR23, bispecific anti-human CD70/KWAR23, and anti-human CD47 antibody (n = 4). Mean ± SEM is shown. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (unpaired two-tailed Student's t test).
Ring, N. G., Herndler-Brandstetter, D., Weiskopf, K., Shan, L., Volkmer, J. P., George, B. M., ... & Zheng, Y. (2017). Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. Proceedings of the National Academy of Sciences, 114(49), E10578-E10585.
Specifications
- Host Species
- Mouse
- Derivation
- Humanized (from mouse)
- Type
- IgG1 - kappa
- Specificity
- CD70 (tumor necrosis factor superfamily member 7, TNFSF7, CD27LG, CD27L) [Homo sapiens]
- Species Reactivity
- Human
- Applications
- ELISA, FC, IP, FuncS, IF, Neut, ICC
- CAS
- 1165740-62-4
- Generic Name
- vorsetuzumab
- MW
- 146.1 kDa
- Related Disease
- Autoimmune diseases
Product Property
- Purity
- Purity >95% by SDS-PAGE.
Applications
- Application Notes
- The CD70 antibody has been reported in applications of Inhib, In vitro experiments.
Target
- Alternative Names
- vorsetuzumab;1165740-62-4;SGN-70;h1F6;CD70;CD70 molecule;CD27LG, TNFSF7, tumor necrosis factor (ligand) superfamily, member 7;CD70 antigen;CD27L;CD27-L;CD27 ligand;Ki-24 antigen;surface antigen CD70;tumor necrosis factor ligand superfamily member 7;tumor
- Gene ID
- 970
- UniProt ID
- P32970
Related Resources
Please refer to Vorsetuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Vorsetuzumab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Vorsetuzumab"
Afuco™ Anti-CD70 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H76)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Humanized (from mouse) antibody to Human CD70. It is a monoclonal antibody designed for the treatment of cancer.
See other products for "CD70"
Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibodies
Human Antibodies
Neutralizing Antibodies
Blocking Antibodies
IgG Antibodies
ADCC Enhanced Antibodies
ScFv Antibodies
Fab Antibodies
Hexamer Antibodies
FC Reagents & Kits
ScFv-Fc Chimeras
Extracellular Vesicle Antibodies
IHC Kits & Antibodies
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-882 | Anti-Human CD70 Recombinant Antibody (Vorsetuzumab Mafodotin) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG1 - kappa |
| TAB-335LC-F(E) | Human Anti-CD70 Recombinant Antibody; Fab Fragment (TAB-335LC-F(E)) | ELISA | Humanized Fab |
| TAB-342LC-F(E) | Human Anti-CD70 Recombinant Antibody; Fab Fragment (TAB-342LC-F(E)) | FC | Humanized Fab |
| TAB-343LC-F(E) | Human Anti-CD70 Recombinant Antibody; Fab Fragment (TAB-343LC-F(E)) | FC | Humanized Fab |
| TAB-344LC-F(E) | Human Anti-CD70 Recombinant Antibody; Fab Fragment (TAB-344LC-F(E)) | FC | Humanized Fab |
Customer Reviews and Q&As
Customer Review
Q&As
Jessica Hill
Excellent for CD70 Studies
Excellent for CD70 Studies
The Anti-Human CD70 Therapeutic Antibody (vorsetuzumab) has been excellent for our CD70 detection assays. Its specificity and sensitivity are top-notch, providing clear and reliable results. This antibody has significantly improved the accuracy of our experiments and saved us a lot of troubleshooting time.
22.Feb,23
David Adams
Reliable in Immunoassays
Reliable in Immunoassays
We incorporated this antibody into our immunoassays, and it has been a great asset. The specificity for CD70 is precise, allowing for accurate detection and analysis. The reliable performance has made it an invaluable tool in our lab.
29.May,22
Megan Martinez
Consistent High-Quality Results
Consistent High-Quality Results
This antibody has proven to be consistent and reliable in our assays. The high-quality, reproducible results have significantly improved our experiments, making it a crucial part of our research toolkit. The strong affinity and specificity for CD70 have been particularly beneficial.
13.Aug,21
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-H76, RRID: AB_3112047)
Copy citation
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-YJ-3.jpg)
Application: ELISA
Application: WB, ELISA, IF
Application: SPR, Inhib, FuncS
Application: WB, ELISA, IF, FuncS, Apop, BA
Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: WB, ELISA, FC, IHC, IF, IP
Application: ELISA, Block, WB, FC, IP
-2.png)
Application: WB, ELISA, FuncS
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
